Accrete Health Partners Invests in ReveloHealth to Expand iCALIBRATE Platform

May 27, 2026
ReveloHealth has received a strategic investment from Accrete Health Partners, the digital venture arm of Bon Secours Mercy Health, to expand its iCALIBRATE platform and improve contract performance and reimbursement accuracy.

ReveloHealth has received a strategic investment from Accrete Health Partners, the digital venture arm of Bon Secours Mercy Health, announced in a press release. The funding aims to strengthen contract performance and reimbursement accuracy across health systems, provider groups, and payer relationships.

ReveloHealth plans to use the investment to expand its iCALIBRATE platform and accelerate its national deployments. The platform integrates payer contract terms, claims data, and reimbursement logic to identify discrepancies early in the payment process.

Bon Secours Mercy Health will deploy iCALIBRATE across its physician network to support standardized contract validation and revenue integrity processes. Jason Szczuka, president of Accrete Health Partners and chief digital officer of Bon Secours Mercy Health, will join ReveloHealth's board of directors.

ReveloHealth stated that it will continue to invest in platform innovation, team growth, and partnerships with health systems and provider groups seeking greater control over reimbursement and contract performance.

We hope you enjoyed this article

Free newsletter

Enterprise AI Brief

Weekly report on AI business applications, enterprise software releases, automation tools, and industry implementations.

Whitepaper

Tensordyne Napier: What If One Rack Could Do the Work of Nine?

Tensordyne

This Tensordyne whitepaper presents Napier, an inference-focused AI processor and rack-scale system based on the company’s TDN Math logarithmic number system. It examines infrastructure requirements for large mixture-of-experts and agentic models, compares major inference architecture approaches, and details the TDN AIP processor, TDN72 pod, TDN Link fabric, and Napier Ultra configuration. The paper reports simulation-based performance, cost, and accuracy-validation results, including Tensordyne’s projected comparison of one Napier rack with a nine-rack Nvidia Rubin plus Groq deployment; the chip is reported as taped out and in fabrication.

Read more
Free, six days a week

Daily AI Brief: the AI news that matters, in your inbox.